Darryl Drake Jr. Named President of Valor as Vector Science and Therapeutics Targets the Performance Medicine Market
SAN BERNARDINO, Calif., July 8, 2026 /PRNewswire/ -- Vector Science and Therapeutics Corp. (TSXV: PAIN), a pharmaceutical-grade peptide and precision drug delivery company, today announced that Darryl Drake Jr. serves as President of Valor, its athlete and performance division, and...
SAN BERNARDINO, Calif., July 8, 2026 /PRNewswire/ -- Vector Science and Therapeutics Corp. (TSXV: PAIN), a pharmaceutical-grade peptide and precision drug delivery company, today announced that Darryl Drake Jr. serves as President of Valor, its athlete and performance division, and...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.